China pharmaceutical manufacturing industry, 2012


#111343

218pages

Reports From China

$ 2980

In Stock


China pharmaceutical manufacturing industry, 2012 is valuable for anyone who wants to invest in the pharmaceutical manufacturing industry, to get Chinese investments; to import into China or export from China, to build factories and take advantage of lower costs in China, to partner with one of the key Chinese corporations, to get market shares as China is boosting its domestic needs; to forecast the future of the world economy as China is leading the way; or to compete in the segment. The report provides in-depth analysis and detailed insight into the pharmaceutical manufacturing industry, market drivers, key enterprises and their strategies, as well as technologies and investment status, risks and trends.
Data sources: Governmental statistics organizations, market research (monitoring) centers, industry associations and institutions, import and export statistics organizations, and others.

This report is divided into 9 parts 19 chapters as follow:

Part 1 Industry Overview
1 Industry definition and development overview
2 Industry macroscopic environment and its influence analysis
3 Industry international market analysis
4 Industry domestic market analysis

Part 2 Basic indices
5 Analysis of the industry's scale and condition: 2007-2011
6 Status analysis of gross assets analysis: 2007-2011

Part 3 Economic operation
7 Analysis of gross industrial output: 2007-2011
8 Industry sales income analysis: 2007-2011
9 Industry gross profit analysis
10 Industry import/export analysis in 2011

Part 4 Competition landscape
11 Industry competition landscape analysis
12 Industry key enterprises' competitive power comparison (top 20)

Part 5 Key enterprises
13 Comparative analysis of the economic indicators of the industry's key enterprises

Part 6 Business strategy
14. Development bottlenecks and coping strategies in Industry
15 Enterprise development strategy analysis and recommendations in Industry

Part 7 Market investment
16 Comparison and analysis of investment activity coefficient and rate of return on investment in Industry
17 Industry investment environment and risks analysis

Part 8 Technology
18 Status and trends of the newest technology applications in Industry

Part 9 Developments and trends
19 Development trends and operation capacity forecast for 2012-2016
Table Of Content

Part 1 Industry Overview
1 Definition and development of pharmaceutical manufacturing industry
1.1 Definition of the industry and its core products 
1.2 Main characteristics of the industry and a history of its development 

2 Macro environment and impact analysis of pharmaceutical manufacturing industry
2.1 Current macroeconomic developments and trends 
2.2 Latest industry policies and related laws and regulations 
2.3 Upstream, downstream industry development status 
2.3.1 Upstream industries 
2.3.2 Downstream industries 

3 International market analysis of pharmaceutical manufacturing industry
3.1 Current development of its international market 
3.2 Levels of development in key countries and regions 
3.3 Analysis of movements and trends in the international market 

4 Domestic market analysis of pharmaceutical manufacturing industry
4.1 Current development of its domestic market 
4.2 Trends in the domestic market 
4.3 Market development of the main industries and sub-industries 

Part 2 Basic indices
5 Size analysis of pharmaceutical manufacturing industry during 2006-2011
5.1 Analysis on number of enterprises: 2006-2011 
5.1.1 Overall situation 
5.1.2 Gross industrial output value by size 
5.1.3 Gross industrial output value by ownership 
5.1.4 Regional analysis 
5.2 Analysis on number of loss-making enterprises: 2006-2011 
5.2.1 Overall situation 
5.2.2 Gross industrial output value by size 
5.2.3 Gross industrial output value by ownership 
5.2.4 Regional analysis 
5.3 Total loss in 2006-2011 
5.3.1 Overall situation 
5.3.2 Gross industrial output value by size 
5.3.3 Gross industrial output value by ownership 
5.3.4 Regional analysis 
5.4 Analysis on number of employees: 2006-2011 
5.4.1 Overall situation 
5.4.2 Gross industrial output value by size 
5.4.3 Gross industrial output value by ownership 
5.4.4 Regional analysis 

6 Asset analysis of pharmaceutical manufacturing industry during 2006-2011
6.1 Status and analysis of gross assets: 2006-2011 
6.1.1 Overall situation 
6.1.2 Gross industrial output value by size 
6.1.3 Gross industrial output value by ownership 
6.1.4 Regional analysis 
6.2 Status of industry's fixed assets: 2006-2011 
6.2.1 Overall situation 
6.2.2 Gross industrial output value by size 
6.2.3 Gross industrial output value by ownership 
6.2.4 Regional analysis 
6.3 Status of industry's current assets: 2006-2011 
6.3.1 Overall situation 
6.3.2 Gross industrial output value by size 
6.3.3 Gross industrial output value by ownership 
6.3.4 Regional analysis 

Part 3 Economic operation
7 Gross industrial output value analysis of pharmaceutical manufacturing industry during 2006-2011
7.1 Gross industrial output value of the industry: 2006-2011 
7.1.1 Overall situation 
7.1.2 Gross industrial output value by size 
7.1.3 Gross industrial output value by ownership 
7.2 Distribution of gross industrial output value by region: 2011 
7.3 Comparison of the top 20 enterprises (based on gross output value) 

8 Sales revenue analysis of pharmaceutical manufacturing industry during 2006-2011
8.1 Total industry sales revenue: 2006-2011 
8.1.1 Overall situation 
8.1.2 Gross industrial output value by size 
8.1.3 Gross industrial output value by ownership 
8.2 Regional distribution status of sales income: 2011 
8.3 Comparison of the top 20 enterprises (based on sales revenue) 

9 Total profits analysis of pharmaceutical manufacturing industry during 2006-2011
9.1 Gross profit of the industry: 2006-2011 
9.1.1 Overall situation 
9.1.2 Gross industrial output value by size 
9.1.3 Gross industrial output value by ownership 
9.2 Distribution of total profits by region: 2011 
9.3 Comparison of the top 20 enterprises (based on gross profit) 

10 Import and export analysis of pharmaceutical manufacturing industry in 2011
10.1 Monthly import/export of the industry: 2011 
10.1.1 Monthly import of the industry: 2011 
10.1.2 Monthly export of the industry: 2011 
10.2 Import/export distribution of the industry by customs and country: 2011 
10.2.1 Import distribution of the industry by customs: 2011 
10.2.2 Export distribution of the industry by country: 2011 
10.3 Distribution of import/export product categories in the book, newspapers and magazine printing industry: 2011 
10.3.1 Distribution of import product categories in the book, newspapers and magazine printing industry: 2011 
10.3.2 Distribution of export product categories in the book, newspapers and magazine printing industry: 2011 

Part 4 Competitive landscape
11 Competitive landscape analysis of pharmaceutical manufacturing industry
11.1 Competitive landscape of regional markets 
11.1.1 Distribution by region 
11.1.2 Distribution by province, city, and autonomous region 
11.2 Comparison of the enterprises' market share 

12 Comparative analysis on the competitiveness of key enterprises in pharmaceutical manufacturing industry
12.1 Comparative analysis of the key enterprises' total assets 
12.2 Comparative analysis of the key enterprises' employees 
12.3 Comparative analysis of the key enterprises' annual revenues 
12.4 Comparison analysis of key enterprises' export turnover value 
12.5 Comparison analysis of key enterprises' total profit 
12.6 Comparison of key enterprises' overall competitive power 

Part 5 Key enterprises
13 Comparative analysis on the economic indicators of key enterprises in pharmaceutical manufacturing industry
13.1 Yangtze River Pharmaceutical Group Co., Ltd 
A Enterprise's basic information 
B Enterprise's business operation analysis 
C Assets and liabilities analysis for the enterprise 
D Enterprise' operating expense and cost analysis 
13.2 Harbin Pharmaceutical Group Co., Ltd 
A Enterprise's basic information 
B Enterprise's business operation analysis 
C Assets and liabilities analysis for the enterprise 
D Enterprise' operating expense and cost analysis 
13.3 Jilin Xiuzheng Pharmaceutical Group Co., Ltd 
A Enterprise's basic information 
B Enterprise's business operation analysis 
C Assets and liabilities analysis for the enterprise 
D Enterprise' operating expense and cost analysis 
13.4 CSPC Pharmaceutical Group Limited 
A Enterprise's basic information 
B Enterprise's business operation analysis 
C Assets and liabilities analysis for the enterprise 
D Enterprise' operating expense and cost analysis 
13.5 Weigao Holding Company Limited 
A Enterprise's basic information 
B Enterprise's business operation analysis 
C Assets and liabilities analysis for the enterprise 
D Enterprise' operating expense and cost analysis 
13.6 Northeast Pharmaceutical Group Co., Ltd 
A Enterprise's basic information 
B Enterprise's business operation analysis 
C Assets and liabilities analysis for the enterprise 
D Enterprise' operating expense and cost analysis 
13.7 Bayer HealthCare Co., Ltd 
A Enterprise's basic information 
B Enterprise's business operation analysis 
C Assets and liabilities analysis for the enterprise 
D Enterprise' operating expense and cost analysis 
13.8 North China Pharmaceutical Group Corp. 
A Enterprise's basic information 
B Enterprise's business operation analysis 
C Assets and liabilities analysis for the enterprise 
D Enterprise' operating expense and cost analysis 
13.9 Xinxiang Liuzhuang Agriculture- Industry-Commerce United Company 
A Enterprise's basic information 
B Enterprise's business operation analysis 
C Assets and liabilities analysis for the enterprise 
D Enterprise' operating expense and cost analysis 
13.10 Xi'an Janssen Pharmaceutical Ltd 
A Enterprise's basic information 
B Enterprise's business operation analysis 
C Assets and liabilities analysis for the enterprise 
D Enterprise' operating expense and cost analysis 
13.11 Henan Caixin Group Co., Ltd 
A Enterprise's basic information 
B Enterprise's business operation analysis 
C Assets and liabilities analysis for the enterprise 
D Enterprise' operating expense and cost analysis 
13.12 Yishui Dadi Corn Developing Co., Ltd 
A Enterprise's basic information 
B Enterprise's business operation analysis 
C Assets and liabilities analysis for the enterprise 
D Enterprise' operating expense and cost analysis 
13.13 Pfizer Pharmaceuticals Limited 
A Enterprise's basic information 
B Enterprise's business operation analysis 
C Assets and liabilities analysis for the enterprise 
D Enterprise' operating expense and cost analysis 
13.14 Novo Nordisk (China) Pharmaceuticals Co., Ltd 
A Enterprise's basic information 
B Enterprise's business operation analysis 
C Assets and liabilities analysis for the enterprise 
D Enterprise' operating expense and cost analysis 
13.15 Tianjin Zhongxin Pharmaceutical Group Corporation Limited 
A Enterprise's basic information 
B Enterprise's business operation analysis 
C Assets and liabilities analysis for the enterprise 
D Enterprise' operating expense and cost analysis 
13.16 Reyoung Pharmaceutical Co., Ltd 
A Enterprise's basic information 
B Enterprise's business operation analysis 
C Assets and liabilities analysis for the enterprise 
D Enterprise' operating expense and cost analysis 
13.17 Shijiazhuang PharmaGroup Zhongrun Pharmaceutical (Inner Mongolia) Co., ltd 
A Enterprise's basic information 
B Enterprise's business operation analysis 
C Assets and liabilities analysis for the enterprise 
D Enterprise' operating expense and cost analysis 
13.18 Shanghai Roche Pharmaceuticals Limited 
A Enterprise's basic information 
B Enterprise's business operation analysis 
C Assets and liabilities analysis for the enterprise 
D Enterprise' operating expense and cost analysis 
13.19 Zhejiang Medicine Co., Ltd Xinchang Pharmaceutical Factory 
A Enterprise's basic information 
B Enterprise's business operation analysis 
C Assets and liabilities analysis for the enterprise 
D Enterprise' operating expense and cost analysis 
13.20 Huiren Group Co., Ltd 
A Enterprise's basic information 
B Enterprise's business operation analysis 
C Assets and liabilities analysis for the enterprise 
D Enterprise' operating expense and cost analysis 

Part 6 Business strategy
14 Development bottlenecks of the pharmaceutical manufacturing industry and counter strategies
14.1 Development bottlenecks 
14.2 Coping strategies 

15 Analysis of enterprise development strategies in pharmaceutical manufacturing industry and recommendations
15.1 Analysis of enterprise business strategies and recommendations 
15.2 Analysis of enterprise marketing strategies and recommendations 

Part 7 Market investment
16 Comparison and analysis of investment activity coefficients and investment returns in the industry
16.1 Comparative analysis of the industry activity coefficients 
16.1.1 Related industry activity coefficient comparison in 2011 
16.1.2 Analysis of the industry activity coefficients: 2006-2011 
16.1.3 Recommendations 
16.2 Comparison and analysis of the industry's investment returns 
16.2.1 Comparison of investment returns in related industries: 2011 
16.2.2 Analysis on investment returns of the industry: 2011 
16.2.3 Recommendations 

17 Analysis of investment environment and investment risks of the pharmaceutical manufacturing industry
17.1 Analysis of the industry's investment environment 
17.2 Analysis of the industry's investment risks 
17.3 Investment recommendations 

Part 8 Technology
18 Current situation and trends of the newest technology applications in pharmaceutical manufacturing industry
18.1 Current situation of the newest technology applications 
18.2 Trends in technological development in the industry 

Part 9 Developments and trends
19 Development trends and operating capability forecast of pharmaceutical manufacturing industry
19.1 Development trends 
19.2 Operation capacity forecast for 2012-2015 
19.2.1 Total assets forecast in 2012-2015 
19.2.2 Overall industrial output value forecast: 2012-2015 
19.2.3 Sales revenue forecast: 2012-2015 
19.2.4 Total revenue forecast: 2012-2015 

Up-to-date list of Chinese pharmaceutical standards 7
Number of enterprises in the pharmaceutical manufacturing industry: 2006-2011 28
Number of enterprises in the pharmaceutical manufacturing industry by size: 2006-2011 30
Number of enterprises in the pharmaceutical manufacturing industry by ownership: 2006-2011 30
Distribution of enterprises in the pharmaceutical manufacturing industry by region in 2011 31
Distribution of enterprises in the pharmaceutical manufacturing industry by province/municipality in 2011 31
Number of loss-making enterprises in the pharmaceutical manufacturing industry: 2006-2011 33
Number of loss-making enterprises in the pharmaceutical manufacturing industry by size: 2006-2011 35
Number of loss-making enterprises in the pharmaceutical manufacturing industry by ownership: 2006-2011 35
Distribution of loss-making enterprises in the pharmaceutical manufacturing industry by region in 2011 36
Distribution of loss-making enterprises in the pharmaceutical manufacturing industry by province/municipality in 2011 36
Total loss of enterprises in the pharmaceutical manufacturing industry: 2006-2011 38
Total loss of enterprises in the pharmaceutical manufacturing industry by size: 2006-2011 40
Total loss of enterprises in the pharmaceutical manufacturing industry by ownership: 2006-2011 40
Total loss of enterprises in the pharmaceutical manufacturing industry by region in 2011 41
Total loss of enterprises in the pharmaceutical manufacturing industry by province/municipality in 2011 41
Number of employees in the pharmaceutical manufacturing industry: 2006-2011 43
Number of employees of enterprises in the pharmaceutical manufacturing industry by size: 2006-2011 44
Number of employees of enterprises in the pharmaceutical manufacturing industry by ownership: 2006-2011 44
Number of employees in the pharmaceutical manufacturing industry by region in 2011 45
Number of employees in the pharmaceutical manufacturing industry by province/municipality in 2011 45
Total assets in the pharmaceutical manufacturing industry: 2006-2011 47
Total assets of enterprises in the pharmaceutical manufacturing industry by size: 2006-2011 48
Total assets of enterprises in the pharmaceutical manufacturing industry by ownership: 2006-2011 48
Total assets in the pharmaceutical manufacturing industry by region in 2011 49
Total assets in the pharmaceutical manufacturing industry by province/municipality in 2011 49
Fixed assets in the pharmaceutical manufacturing industry: 2006-2011 51
Fixed assets of enterprises in the pharmaceutical manufacturing industry by size: 2006-2011 52
Fixed assets of enterprises in the pharmaceutical manufacturing industry by ownership: 2006-2011 52
Fixed assets in the pharmaceutical manufacturing industry by region in 2011 53
Fixed assets in the pharmaceutical manufacturing industry by province/municipality in 2011 53
Current assets in the pharmaceutical manufacturing industry: 2006-2011 55
Current assets of enterprises in the pharmaceutical manufacturing industry by size: 2006-2011 56
Current assets of enterprises in the pharmaceutical manufacturing industry by ownership: 2006-2011 56
Current assets in the pharmaceutical manufacturing industry by region in 2011 57
Current assets in the pharmaceutical manufacturing industry by province/municipality in 2011 57
Gross industrial output value in the pharmaceutical manufacturing industry: 2006-2011 59
Gross industrial output value of enterprises in the pharmaceutical manufacturing industry by size: 2006-2011 61
Gross industrial output value of enterprises in the pharmaceutical manufacturing industry by ownership: 2006-2011 61
Gross industrial output value in the pharmaceutical manufacturing industry by region in 2011 62
Gross industrial output value in the pharmaceutical manufacturing industry by province/municipality in 2011 62
Comparison of top 20 enterprises in the industry (based on gross industrial output value) 64
Sales revenue in the pharmaceutical manufacturing industry: 2006-2011 66
Sales revenue of enterprises in the pharmaceutical manufacturing industry by size: 2006-2011 68
Sales revenue of enterprises in the pharmaceutical manufacturing industry by ownership: 2006-2011 68
Sales revenue in the pharmaceutical manufacturing industry by region in 2010 69
Sales revenue in the pharmaceutical manufacturing industry by province/municipality in 2010 69
Comparison of top 20 enterprises in the industry (based on sales revenue) 71
Total profits in the pharmaceutical manufacturing industry: 2006-2011 73
Total profits of enterprises in the pharmaceutical manufacturing industry by size: 2006-2011 75
Total profits of enterprises in the pharmaceutical manufacturing industry by ownership: 2006-2011 75
Total profits in the pharmaceutical manufacturing industry by region in 2011 76
Total profits in the pharmaceutical manufacturing industry by province/municipality in 2011 76
Comparison of top 20 enterprises in the industry (based on total profits) 78
Serial numbers and names of imported and exported pharmaceuticals 80
Monthly import statistics of pharmaceuticals in 2011 81
Monthly export statistics of pharmaceuticals in 2011 82
Top 20 Chinese customs with the highest pharmaceutical imports in 2011 83
Top 20 countries with the highest imports of Chinese pharmaceuticals in 2011 84
Distribution of import product categories of the pharmaceutical manufacturing industry in 2011 87
Distribution of export product categories of the pharmaceutical manufacturing industry in 2011 88
Competitive landscape of the pharmaceutical manufacturing industry by region 89
Competitive landscape of the pharmaceutical manufacturing industry by province, municipality and autonomous region 90
Comparison of enterprises market share 91
Comparative analysis of the key enterprises total assets 93
Comparative analysis of the key enterprises employees 95
Comparative analysis of the key enterprises annual revenues 96
Comparison analysis of key enterprises export turnover value 97
Comparative analysis of the key enterprises gross profit 98
Comparative analysis of the overall competitiveness of key enterprises in the industry 99
General information about Yangtze River Pharmaceutical Group Co., Ltd 101
Analysis of business performance of Yangtze River Pharmaceutical Group Co., Ltd 102
Analysis of liabilities of Yangtze River Pharmaceutical Group Co., Ltd 103
Analysis of operating expenses and costs of Yangtze River Pharmaceutical Group Co., Ltd 103
General information about Harbin Pharmaceutical Group Co., Ltd 104
Analysis of business performance of Harbin Pharmaceutical Group Co., Ltd 105
Analysis of liabilities of Harbin Pharmaceutical Group Co., Ltd 106
Analysis of operating expenses and costs of Harbin Pharmaceutical Group Co., Ltd 106
General information about Jilin Xiuzheng Pharmaceutical Group Co., Ltd 107
Analysis of business performance of Jilin Xiuzheng Pharmaceutical Group Co., Ltd 109
Analysis of liabilities of Jilin Xiuzheng Pharmaceutical Group Co., Ltd 110
Analysis of operating expenses and costs of Jilin Xiuzheng Pharmaceutical Group Co., Ltd 110
General information about CSPC Pharmaceutical Group Limited 111
Analysis of business performance of CSPC Pharmaceutical Group Limited 112
Analysis of liabilities of CSPC Pharmaceutical Group Limited 113
Analysis of operating expenses and costs of CSPC Pharmaceutical Group Limited 113
General information about Weigao Holding Company Limited 114
Analysis of business performance of Weigao Holding Company Limited 115
Analysis of liabilities of Weigao Holding Company Limited 116
Analysis of operating expenses and costs of Weigao Holding Company Limited 116
General information about Northeast Pharmaceutical Group Co., Ltd 117
Analysis of business performance of Northeast Pharmaceutical Group Co., Ltd 118
Analysis of liabilities of Northeast Pharmaceutical Group Co., Ltd 119
Analysis of operating expenses and costs of Northeast Pharmaceutical Group Co., Ltd 119
General information about Bayer HealthCare Co., Ltd 120
Analysis of business performance of Bayer HealthCare Co., Ltd 121
Analysis of liabilities of Bayer HealthCare Co., Ltd 122
Analysis of operating expenses and costs of Bayer HealthCare Co., Ltd 122
General information about North China Pharmaceutical Group Corp. 123
Analysis of business performance of North China Pharmaceutical Group Corp. 124
Analysis of liabilities of North China Pharmaceutical Group Corp. 125
Analysis of operating expenses and costs of North China Pharmaceutical Group Corp. 125
General information about Xinxiang Liuzhuang Agriculture- Industry-Commerce United Company 126
Analysis of business performance of Xinxiang Liuzhuang Agriculture- Industry-Commerce United Company 128
Analysis of liabilities of Xinxiang Liuzhuang Agriculture- Industry-Commerce United Company 129
Analysis of operating expenses and costs of Xinxiang Liuzhuang Agriculture- Industry-Commerce United Company 129
General information about Xi'an Janssen Pharmaceutical Ltd 130
Analysis of business performance of Xi'an Janssen Pharmaceutical Ltd 131
Analysis of liabilities of Xi'an Janssen Pharmaceutical Ltd 132
Analysis of operating expenses and costs of Xi'an Janssen Pharmaceutical Ltd 132
General information about Henan Caixin Group Co., Ltd 133
Analysis of business performance of Henan Caixin Group Co., Ltd 134
Analysis of liabilities of Henan Caixin Group Co., Ltd 135
Analysis of operating expenses and costs of Henan Caixin Group Co., Ltd 135
General information about Yishui Dadi Corn Developing Co., Ltd 136
Analysis of business performance of Yishui Dadi Corn Developing Co., Ltd 137
Analysis of liabilities of Yishui Dadi Corn Developing Co., Ltd 138
Analysis of operating expenses and costs of Yishui Dadi Corn Developing Co., Ltd 138
General information about Pfizer Pharmaceuticals Limited 139
Analysis of business performance of Pfizer Pharmaceuticals Limited 140
Analysis of liabilities of Pfizer Pharmaceuticals Limited 141
Analysis of operating expenses and costs of Pfizer Pharmaceuticals Limited 141
General information about Novo Nordisk (China) Pharmaceuticals Co., Ltd 142
Analysis of business performance of Novo Nordisk (China) Pharmaceuticals Co., Ltd 143
Analysis of liabilities of Novo Nordisk (China) Pharmaceuticals Co., Ltd 144
Analysis of operating expenses and costs of Novo Nordisk (China) Pharmaceuticals Co., Ltd 144
General information about Tianjin Zhongxin Pharmaceutical Group Corporation Limited 145
Analysis of business performance of Tianjin Zhongxin Pharmaceutical Group Corporation Limited 147
Analysis of liabilities of Tianjin Zhongxin Pharmaceutical Group Corporation Limited 148
Analysis of operating expenses and costs of Tianjin Zhongxin Pharmaceutical Group Corporation Limited 148
General information about Reyoung Pharmaceutical Co., Ltd 149
Analysis of business performance of Reyoung Pharmaceutical Co., Ltd 150
Analysis of liabilities of Reyoung Pharmaceutical Co., Ltd 151
Analysis of operating expenses and costs of Reyoung Pharmaceutical Co., Ltd 151
General information about Shijiazhuang PharmaGroup Zhongrun Pharmaceutical (Inner Mongolia) Co., ltd 152
Analysis of business performance of Shijiazhuang PharmaGroup Zhongrun Pharmaceutical (Inner Mongolia) Co., ltd 154
Analysis of liabilities of Shijiazhuang PharmaGroup Zhongrun Pharmaceutical (Inner Mongolia) Co., ltd 155
Analysis of operating expenses and costs of Shijiazhuang PharmaGroup Zhongrun Pharmaceutical (Inner Mongolia) Co., ltd 155
General information about Shanghai Roche Pharmaceuticals Limited 156
Analysis of business performance of Shanghai Roche Pharmaceuticals Limited 157
Analysis of liabilities of Shanghai Roche Pharmaceuticals Limited 158
Analysis of operating expenses and costs of Shanghai Roche Pharmaceuticals Limited 158
General information about Zhejiang Medicine Co., Ltd Xinchang Pharmaceutical Factory 159
Analysis of business performance of Zhejiang Medicine Co., Ltd Xinchang Pharmaceutical Factory 161
Analysis of liabilities of Zhejiang Medicine Co., Ltd Xinchang Pharmaceutical Factory 162
Analysis of operating expenses and costs of Zhejiang Medicine Co., Ltd Xinchang Pharmaceutical Factory 162
General information about Huiren Group Co., Ltd 163
Analysis of business performance of Huiren Group Co., Ltd 164
Analysis of liabilities of Huiren Group Co., Ltd 165
Analysis of operating expenses and costs of Huiren Group Co., Ltd 165
Related industry activity coefficient comparison in 2011 173
Industry activity coefficient analysis: 2006-2011 175
Comparison of related industries return on investment in 2011 177
Analysis on industry rate of return on investment in related industry in 2006-2011 178
Forecast of industrys total assets in 2012-2015 189
Industry gross output value forecast for 2012-2015 190
Industry sales revenue forecast for 2012-2015 191
Industry gross profit forecast for 2012-2015 192